How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Surgical Biopsy Needles Market
- By Needle Type: Core Needle Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automated Biopsy Needles, Manual Biopsy Needles
- By Application: Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Kidney Biopsy, Bone Biopsy
- By Material: Stainless Steel, Titanium, Nickel-Titanium Alloy (Nitinol)
- By End User: Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Specialty Clinics
- By Product Design: Disposable Biopsy Needles, Reusable Biopsy Needles
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Core Needle Biopsy Needles leads By Needle Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Surgical Biopsy Needles Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Needle Type 5
Application 6
Material 3
End User 4
Product Design 2
Companies profiled
BD (Becton
Dickinson and Company)
Medtronic
Cook Medical
Argon Medical Devices
Merit Medical Systems
Hologic Inc.
C.R. Bard (now part of BD)
B. Braun Melsungen AG
Smiths Medical
Teleflex Incorporated
Stryker Corporation
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BD (Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Dickinson and Company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Cook Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Argon Medical Devices
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Merit Medical Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hologic Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →C.R. Bard (now part of BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Smiths Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Teleflex Incorporated
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cardinal Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Terumo Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Nipro Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Conmed Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,870M by 2033 · 4.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Core Needle Biopsy Needles55.4
- Fine Needle Aspiration (FNA) Needles13.5
- Vacuum-Assisted Biopsy Needles7.5
- Automated Biopsy Needles12.8
- Manual Biopsy Needles10.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$670.6M → $841.9M · 2.9%
Europe$467.4M → $658.3M · 4.4%
Asia Pacific$426.7M → $655.0M · 5.5%
Latin America$264.2M → $382.2M · 4.7%
Middle East and Africa$203.2M → $291.2M · 4.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.372026
4.382027
4.382028
4.402029
4.402030
4.422031
4.442032
4.442033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BD (Becton11.8
- Dickinson and Company)21.8
- Medtronic9.6
- Cook Medical10.0
- Argon Medical Devices8.3
- Merit Medical Systems10.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Needle Type22.5%
Application10.2%
Material27.5%
End User26.6%
Product Design13.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America29.8
- Europe23.3
- Asia Pacific23.2
- Latin America13.5
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BD (Becton | 79 | 83 | 80 | 75 | 76 | 79 | 79 |
| Dickinson and Company) | 93 | 70 | 92 | 70 | 72 | 70 | 78 |
| Medtronic | 63 | 85 | 63 | 65 | 70 | 75 | 70 |
| Cook Medical | 80 | 73 | 62 | 70 | 67 | 71 | 71 |
| Argon Medical Devices | 74 | 54 | 59 | 59 | 64 | 52 | 60 |
| Merit Medical Systems | 66 | 63 | 69 | 55 | 54 | 58 | 61 |
| Hologic Inc. | 57 | 61 | 54 | 47 | 49 | 55 | 54 |
| C.R. Bard (now part of BD) | 35 | 60 | 40 | 38 | 59 | 55 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BD (Becton
- Dickinson and Company)
- Medtronic
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BD (Becton | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Dickinson and Company) | ◐ | − | ◐ | ✓ | ◐ | ✓ |
| Medtronic | ◐ | ◐ | ◐ | − | ◐ | ✓ |
| Cook Medical | ✓ | ✓ | ◐ | − | ◐ | ◐ |
| Argon Medical Devices | ✓ | − | − | ◐ | ◐ | ◐ |
| Merit Medical Systems | ✓ | ◐ | ✓ | − | ◐ | ◐ |
| Hologic Inc. | − | − | ◐ | − | − | − |
| C.R. Bard (now part of BD) | − | ◐ | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BD (Becton79
2Dickinson and Company)78
3Cook Medical71
4Medtronic70
5Merit Medical Systems61
6Argon Medical Devices60
7Hologic Inc.54
8C.R. Bard (now part of BD)48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BD (BectonDickinson and Company)
Challenger2
Strong scale, closing on the leaders.
MedtronicCook Medical
Contender2
Focused players with pockets of strength.
Argon Medical DevicesMerit Medical Systems
Niche2
Specialists in a single segment or region.
Hologic Inc.C.R. Bard (now part of BD)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Needle Type in North America, then scale across Surgical Biopsy Needles Market — a $332M beachhead inside a $5.82B market.
Beachhead (SOM)$332Mobtainable near-term
Serviceable (SAM)$2.06Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Core Needle Biopsy Needles
Best fit — highest urgency & budget in Needle Type.
Economic buyer79 fit
Fine Needle Aspiration (FNA) Needles
Strong fit — clear ROI and a fast path to value.
End user65 fit
Vacuum-Assisted Biopsy Needles
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Needle Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Material
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel30%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Needle Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Surgical Biopsy Needles Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation11%
Closed-won7%
$16.2KCAC
$62KLTV
3.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Surgical Biopsy Needles Market is a durable-growth opportunity — $8.26B by 2033, compounding at 6.9%.
TAM · 2025$4.85Btoday
TAM · 2033$8.26Bforecast
CAGR6.9%2027–2033
Cumulative$57.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.26BTotal addressable market
SAM$2.99BServiceable available market
SOM$574MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.9% CAGR
Demand compounds through 2033, outpacing GDP across Needle Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Needle Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.26BLarge & growingTAM by 2033 at 6.9% CAGR
$2.99BServiceable nowreachable with today’s model
$574MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.44BBear4.5% CAGR
$8.26BBase6.9% CAGR
$10.6BBull9.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Surgical Biopsy Needles Market — a $13.2B market by 2033. Plan: grow share from 10.3% to 17.1%.
Market size · 2033$13.2Btotal addressable
Market CAGR11.5%2027–2033
Target share17.1%from 10.3% today
Revenue ambition$2.25Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.3% | 17.1% | On track |
| Revenue | $1.46B | $2.25B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.7% | 39.4% | On track |
| Customer retention | 88.7% | 94.8% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Needle Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Needle Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $262M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Needle Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Surgical Biopsy Needles Market conversation — a $1.38B market you can size, segment and defend in minutes.
Market size · 2033$1.38Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers981+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Needle Type
Goal Grow share in Needle Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 3 mopayback period
$97K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
BD (BectonDickinson and Company)MedtronicCook MedicalArgon Medical DevicesMerit Medical SystemsHologic Inc.C.R. Bard (now part of BD)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Surgical Biopsy Needles Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Surgical Biopsy Needles Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Surgical Bioadhesive Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportSurgical Binocular Loupe Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportSurgical Belt Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportSurgical Bed Market
Market size, share, segmentation and regional forecast.
$810M market · 2025 base year
View reportSurgical Basin Stands Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportSurgical Assist Services Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportSurgical Assist Equipment Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportSurgical Aspirators Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportSurgical Aspirator Pumps Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportSurgical Arterial Indwelling Needle Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportSurgical Arm Boards Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportSurgical Aortic Valve Replacement Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.